ES2105544T3 - Procedimiento para la preparacion de esferulas de principios activos. - Google Patents

Procedimiento para la preparacion de esferulas de principios activos.

Info

Publication number
ES2105544T3
ES2105544T3 ES94400650T ES94400650T ES2105544T3 ES 2105544 T3 ES2105544 T3 ES 2105544T3 ES 94400650 T ES94400650 T ES 94400650T ES 94400650 T ES94400650 T ES 94400650T ES 2105544 T3 ES2105544 T3 ES 2105544T3
Authority
ES
Spain
Prior art keywords
spherules
preparation
active principles
procedure
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94400650T
Other languages
English (en)
Inventor
Jean-Marie Dollat
Marc Molin
Pascal Theallier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Adisseo France SAS
Original Assignee
Rhone Poulenc Nutrition Animale SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Nutrition Animale SA filed Critical Rhone Poulenc Nutrition Animale SA
Application granted granted Critical
Publication of ES2105544T3 publication Critical patent/ES2105544T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/06—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a liquid medium
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/174—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/10—Shaping or working-up of animal feeding-stuffs by agglomeration; by granulation, e.g. making powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1658—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Husbandry (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN NUEVO PROCESO DE PREPARACION DE ESFERULAS DE UNO O VARIOS PRINCIPIOS ACTIVOS ALIMENTICIOS O MEDICAMENTOSOS DONDE EN UNA PRIMERA ETAPA SE FORMAN ESFERULAS POR DIVISION CONTROLADA DE UNA EMULSION PRIMARIA DE ACEITE EN AGUA EN UN SOLVENTE NO MISCIBLE EN AGUA Y A CONTINUACION EN UNA SEGUNDA ETAPA SE SEPARAN LAS ESFERULAS OBTENIDAS.
ES94400650T 1993-03-31 1994-03-28 Procedimiento para la preparacion de esferulas de principios activos. Expired - Lifetime ES2105544T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9303728A FR2703263B1 (fr) 1993-03-31 1993-03-31 Procédé de préparation de sphérules de principes actifs.

Publications (1)

Publication Number Publication Date
ES2105544T3 true ES2105544T3 (es) 1997-10-16

Family

ID=9445550

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94400650T Expired - Lifetime ES2105544T3 (es) 1993-03-31 1994-03-28 Procedimiento para la preparacion de esferulas de principios activos.

Country Status (12)

Country Link
US (1) US5500415A (es)
EP (1) EP0618001B1 (es)
JP (1) JP2515487B2 (es)
AT (1) ATE156727T1 (es)
CA (1) CA2120290C (es)
DE (1) DE69404885T2 (es)
DK (1) DK0618001T3 (es)
ES (1) ES2105544T3 (es)
FR (1) FR2703263B1 (es)
GR (1) GR3024609T3 (es)
RU (1) RU2145211C1 (es)
UA (1) UA27801C2 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2283821A1 (en) * 1993-11-19 2011-02-16 Alkermes, Inc. Preparation of biodegradable microparticles containing a biologically active agent
WO1998002237A1 (en) * 1996-07-15 1998-01-22 Kemgas Limited Production of powders
DE19642359A1 (de) * 1996-10-14 1998-04-16 Basf Ag Stabile Emulsionen und Trockenpulver von Mischungen fettlöslicher Vitamine, deren Herstellung und Verwendung
DE19838189A1 (de) * 1998-08-24 2000-03-02 Basf Ag Stabile pulverförmige Vitamin- und Carotinoid-Zubereitungen und Verfahren zu deren Herstellung
US6582721B1 (en) 1999-09-17 2003-06-24 Alcon, Inc. Stable carotene-xanthophyll beadlet compositions and methods of use
CN1240438C (zh) * 1999-12-23 2006-02-08 安迪苏法国联合股份有限公司 颗粒状维生素组合物
AU2001272489A1 (en) * 2000-05-31 2001-12-11 Aventis Animal Nutrition S.A. Granular vitamin composition
FR2836827B1 (fr) * 2002-03-07 2010-10-01 Innoform Sa Composition dietetique et cosmetique a base de polymeres naturels reticules immobilisant des actifs
US7008644B2 (en) * 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
US20050186282A1 (en) * 2002-08-01 2005-08-25 The Regents Of The University Of California, A California Corporation Method and compositions for preparing and delivering lipids, other nutrients and medicaments
JP2005534317A (ja) * 2002-08-01 2005-11-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア ルーメンで保護される脂質、他の栄養剤及び薬剤を調整並びに送達するための方法及び配合物
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
RU2238728C1 (ru) * 2003-05-06 2004-10-27 Открытое акционерное общество "Новосибхимфарм" Способ получения раствора никотиновой кислоты для инъекций
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2007081385A2 (en) 2006-01-11 2007-07-19 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
EP2530167A1 (en) 2006-05-11 2012-12-05 Raindance Technologies, Inc. Microfluidic Devices
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2077912B1 (en) 2006-08-07 2019-03-27 The President and Fellows of Harvard College Fluorocarbon emulsion stabilizing surfactants
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
EP4047367A1 (en) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Method for detecting target analytes with droplet libraries
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
WO2010111231A1 (en) 2009-03-23 2010-09-30 Raindance Technologies, Inc. Manipulation of microfluidic droplets
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
EP4484577A3 (en) 2010-02-12 2025-03-26 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9562897B2 (en) 2010-09-30 2017-02-07 Raindance Technologies, Inc. Sandwich assays in droplets
EP3412778A1 (en) 2011-02-11 2018-12-12 Raindance Technologies, Inc. Methods for forming mixed droplets
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP3216872B1 (en) 2011-06-02 2020-04-01 Bio-Rad Laboratories, Inc. Enzyme quantification
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
CN104224542B (zh) * 2014-09-17 2017-03-01 河南农业大学 复方维生素口服液生产制备系统
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
PH12022550553B1 (en) * 2019-10-25 2024-03-08 Unilever Ip Holdings B V Cosmetic composition with enhanced color stability

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2828202A (en) * 1954-10-08 1958-03-25 Sintercast Corp America Titanium tool steel
NL113394C (es) * 1960-04-07
DK135654B (da) * 1966-07-30 1977-06-06 Sumitomo Chemical Co Fremgangsmåde til fremstilling af småkorn af vanduopløselige eller i det væsentlige vanduopløselige faste eller flydende stoffer.
FR1497584A (fr) * 1966-08-11 1967-10-13 Roussel Uclaf Procédé de fabrication de microcapsules
DK111832B (da) * 1966-12-01 1968-10-14 Ferrosan As Fremgangsmåde til fremstilling af koldtvandsdispersible præparater indeholdende fedtopløselige vitaminer i tør partikulær, hældbar form.
JPS5210427B2 (es) * 1972-07-19 1977-03-24
JPS5431085A (en) * 1977-08-12 1979-03-07 Ota Pharma Method of solidifying oily matter
CH642564A5 (de) * 1979-10-26 1984-04-30 Sulzer Ag Statische mischvorrichtung.
WO1984002255A2 (en) * 1982-12-06 1984-06-21 Hydrosyn Systems Inc Lipid pelletization methods, apparatus and products
EP0285682B2 (en) * 1987-04-06 1997-08-06 F. Hoffmann-La Roche Ag Process for the manufacture of vitamin preparations
CA1335748C (en) 1986-09-25 1995-05-30 Jeffrey Lawrence Finnan Crosslinked gelatins
IL88961A (en) * 1988-01-29 1992-07-15 Basf Ag Stable mixtures containing oxidation-sensitive compounds
US5035896A (en) * 1988-06-15 1991-07-30 Warner-Lambert Company Water insoluble drugs coated by coacervated fish gelatin
JP3051945B2 (ja) * 1991-07-22 2000-06-12 大阪瓦斯株式会社 無機質均一微小球体、及びその製造方法

Also Published As

Publication number Publication date
US5500415A (en) 1996-03-19
JP2515487B2 (ja) 1996-07-10
RU94010892A (ru) 1996-08-10
JPH07489A (ja) 1995-01-06
EP0618001B1 (fr) 1997-08-13
RU2145211C1 (ru) 2000-02-10
DK0618001T3 (da) 1997-12-29
UA27801C2 (uk) 2000-10-16
EP0618001A1 (fr) 1994-10-05
DE69404885T2 (de) 1998-01-22
ATE156727T1 (de) 1997-08-15
CA2120290A1 (fr) 1994-10-01
CA2120290C (fr) 1999-04-20
GR3024609T3 (en) 1997-12-31
FR2703263A1 (fr) 1994-10-07
FR2703263B1 (fr) 1995-05-19
DE69404885D1 (de) 1997-09-18

Similar Documents

Publication Publication Date Title
ES2105544T3 (es) Procedimiento para la preparacion de esferulas de principios activos.
DE3767029D1 (de) 5-arylalkyl-4-alkoxy-2(5h)-furanone, zwischenprodukte und verfahren zu ihrer herstellung sowie ihre anwendung als therapeutische wirkstoffe.
AU609981B2 (en) Oil-in-water pesticidal emulsion, process for application
NO974480D0 (no) Anvendelse av vitamin D2 eller vitamin D4 derivater til fremstilling av et medikament for behandling av sekundær hyperparathyreoidisme
NO892379D0 (no) Fremgangsmaate for utvinning av olje ved anvendelse av alkylarylpolyalkoksyolsulfonat-overflateaktive stoffer som mobilitetsregulerende midler.
DE59003557D1 (de) Omega-3-fettsäurehaltige fettemulsion zur intraperitonealen applikation, ihre herstellung und anwendung.
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
DE3671451D1 (de) 4h-triazolo (4,3-a)(1,4) benzodiazepine, verfahren zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende zubereitungen.
IS4190A (is) Hliðstæð aðferð til framleiðslu á 1,5 bensódíasepín afleiðum
DE3481057D1 (de) 2-sulfamoylbenzo(b)thiophen-derivate, ihre herstellung und pharmazeutische zubereitung zur behandlung von erhoehtem augeninnendruck.
WO1988008836A3 (en) Aryl substituted naphthalene, benzoxepine, benzazepine, benzocycloheptene derivatives
DE3888739D1 (de) Submunitions-Wirkteil, sowie Flechettes-Gefechtskopf und Flechettes dafür.
ITMI912181A1 (it) Formulazioni utili per il trattamento della secchezza vaginale
ES2160893T3 (es) Procedimiento y compuestos intermedios para la preparacion de compuestos de fluoroolefinas plaguicidas.
ITRM920384A0 (it) Procedimento per la produzione di leuco coloranti allo zolfo e prodotto ottenuto.
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung
TR27462A (tr) Sübstitüe edilmis sinamik asidi hidroksiamid'leri, bunlarin üretilmesine mahsus usul, bunlari ihtiva eden maddeler ve bunlarin kullanilmasi.
DE69619812D1 (de) Kontinuierliche herstellung von 1,1-difluorethan
DK0579939T3 (da) Phospholipidderivater
ES2021048B3 (es) Un metodo para la preparacion de un derivado de 2,4-diamino-3oxi-pirimidina.
BR8901554A (pt) Processo para produzir formulacoes de microcapsulas aperfeicoadas,formulacao das mesmas,e processos de polimerizacao interfacial e para impedir a formacao de uma emulsao(agua-em-oleo)invertida
NO894516D0 (no) Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.
RU2004196C1 (ru) Способ резекции желудка в эксперименте
JPS5231815A (en) Chinese medicine from konnyak
FI890065A0 (fi) Foerfarande foer framstaellning av 5,8,13, 14-tetrahydrobenz/5,6/isoindolo/2,1-b/isokinolin-8,13-dionderivat.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 618001

Country of ref document: ES